Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANAPC1P5 (ANAPC1 pseudogene 5) is a pseudogene of the human genome (NCBI Gene ID: 100420890, Ensembl: ENSG00000275597). It has no protein-coding function and does not produce any functional RNA or protein product. ANAPC1P5 is most likely named for its sequence homology to the ANAPC1 gene, which encodes a real subunit of the anaphase-promoting complex, a cell cycle-regulating E3 ubiquitin ligase[4][5]. There are no known biological functions, disease associations, or drug interactions for this pseudogene. Pseudogenes like ANAPC1P5 are not considered therapeutic targets, receptors, enzymes, or druggable entities in biomedical research. The inclusion of ANAPC1P5 as a "target" is incorrect, as it is neither a receptor nor a protein-coding gene, and thus should not be considered a legitimate target in pharmacology or molecular biology[4][5]. Additional context: - Pseudogenes are sometimes transcribed, but generally do not encode functional products and are not involved directly in biological pathways or known disease mechanisms. - No molecular classifications (e.g., receptor, enzyme, transporter, transcription factor) apply to ANAPC1P5, aside from "Other" as a pseudogene. - No drugs, mechanisms of action, biomarkers, or safety concerns are associated with ANAPC1P5. If you intended the functional, protein-coding ANAPC1 gene, refer to "anaphase promoting complex subunit 1"[1][2][3], which is a vital regulator of the cell cycle and is associated with cell proliferation, cancer, and other biological functions, but ANAPC1P5 is distinctly a non-functional pseudogene[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANAPC1 pseudogene 5 (ANAPC1P5).